December 15, 2020
Office of Life Sciences
Division of Corporation Finance
U.S. Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549
Re: 908 Devices Inc.
Registration Statement on Form S-1 (File No. 333-250954)
Request for Acceleration
Ladies and Gentlemen:
Pursuant to Rule 460 of the General Rules and Regulations under the Securities Act of 1933, as amended, we wish to advise that as of the date hereof, approximately 860 copies of the Preliminary Prospectus dated December 14, 2020 were distributed to prospective underwriters, institutional investors and prospective dealers in connection with the above captioned Registration Statement.
We wish to advise you that the participating underwriters have informed us that they have complied and will continue to comply with the requirements of Rule 15c2-8 under the Securities Exchange Act of 1934, as amended.
We hereby join in the request of the registrant that the effectiveness of the above-captioned Registration Statement, as amended, be accelerated to 4:00 p.m. Eastern Time, on Thursday, December 17, 2020 or as soon thereafter as practicable.
[Signature page follows]
| Very truly yours, | |||
| Cowen and Company, LLC | |||
| SVB Leerink LLC | |||
| As representatives of the Underwriters | |||
| By: | Cowen and Company, LLC | ||
| By: | /s/ Bill Follis | ||
| Name: | Bill Follis | ||
| Title: | Managing Director | ||
| By: | SVB Leerink LLC | ||
| By: | /s/ Ryan Lindquist | ||
| Name: | Ryan Lindquist | ||
| Title: | Managing Director | ||
[Signature Page to 908 Devices Inc. Acceleration Request]
